Simon Walker : Citation Profile


Are you Simon Walker?

5

H index

2

i10 index

93

Citations

RESEARCH PRODUCTION:

8

Articles

6

Papers

RESEARCH ACTIVITY:

   9 years (2010 - 2019). See details.
   Cites by year: 10
   Journals where Simon Walker has often published
   Relations with other researchers
   Recent citing documents: 13.    Total self citations: 6 (6.06 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pwa900
   Updated: 2021-06-12    RAS profile: 2019-10-31    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Asaria, Miqdad (6)

Authors registered in RePEc who have co-authored more than one work in the last five years with Simon Walker.

Is cited by:

Claxton, Karl (13)

Brouwer, Werner (11)

Sculpher, Mark (10)

Revill, Paul (5)

van Exel, Job (5)

Culyer, Anthony (3)

Attema, Arthur (2)

Asaria, Miqdad (2)

Towse, Adrian (2)

Shah, Koonal (2)

Moramarco, Vito (1)

Cites to:

Claxton, Karl (11)

Sculpher, Mark (10)

Asaria, Miqdad (8)

Rice, Nigel (7)

Brouwer, Werner (5)

Culyer, Anthony (4)

Johannesson, Magnus (3)

Street, Andrew (2)

Martin, Stephen (2)

Howdon, Daniel (2)

Lomas, James (2)

Main data


Where Simon Walker has published?


Journals with more than one article published# docs
PharmacoEconomics4
PharmacoEconomics - Open2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York4

Recent works citing Simon Walker (2021 and 2020)


YearTitle of citing document
2020Opportunity cost neglect in public policy. (2020). Persson, Emil ; Tinghog, Gustav. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:170:y:2020:i:c:p:301-312.

Full description at Econpapers || Download paper

2020A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implications. (2020). Basu, Anirban. In: Journal of Health Economics. RePEc:eee:jhecon:v:70:y:2020:i:c:s0167629619307374.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2020Should Health Economic Evaluations Undertaken from a Societal Perspective Include Net Government Spending Multiplier Effects?. (2020). Pekarsky, Brita ; Karnon, Jonathan. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:4:d:10.1007_s40258-020-00556-x.

Full description at Econpapers || Download paper

2021Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review. (2021). Phelps, Charles E ; Chen, Hui-Han ; Padula, William V. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00606-4.

Full description at Econpapers || Download paper

2020Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy. (2020). Valentine, W J ; Boye, K S ; Norrbacka, K ; Pohlmann, J ; Sapin, H. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01229-1.

Full description at Econpapers || Download paper

2020One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit. (2020). Hall, Peter ; Sutton, Andrew ; Awotwe, Isaac ; Paulden, Mike ; McCabe, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00869-3.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2020Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations. (2020). Richardson, Gerry ; Lomas, James ; Franklin, Matthew. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00907-5.

Full description at Econpapers || Download paper

2021The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best–Worst Scaling Experiment. (2021). , Ruben ; Silvia, ; Hiligsmann, Mickael ; Pokhilenko, Irina. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00966-8.

Full description at Econpapers || Download paper

2021Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs. (2021). Sauboin, Christophe ; Standaert, Baudouin ; Connolly, Mark P ; Leclerc, Quentin J. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00978-4.

Full description at Econpapers || Download paper

2021Cost?effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross?sectoral analysis of an alcohol misuse intervention. (2021). Richardson, Gerry ; Kanaan, Mona ; Coulton, Simon ; Deluca, Paolo ; Drummond, Colin ; Parrott, Steve ; Griffin, Susan ; Walker, Simon ; Ramponi, Francesco. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:972-988.

Full description at Econpapers || Download paper

2020Impact of a Global Pandemic on Health Technology Assessment. (2020). Adler, Amanda ; Lorgelly, Paula K. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-020-00590-9.

Full description at Econpapers || Download paper

Works by Simon Walker:


YearTitleTypeCited
2019Incorporating concerns for equity into health resource allocation. A guide for practitioners In: Working Papers.
[Full Text][Citation analysis]
paper1
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]
paper43
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]
paper20
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]
paper9
2019Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers In: LSE Research Online Documents on Economics.
[Full Text][Citation analysis]
paper7
2019Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.(2019) In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 7
article
2016Using electronic health records to predict costs and outcomes in stable coronary artery disease In: LSE Research Online Documents on Economics.
[Full Text][Citation analysis]
paper2
2017Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2012Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2016Using Linked Electronic Health Records to Estimate Healthcare Costs: Key Challenges and Opportunities In: PharmacoEconomics.
[Full Text][Citation analysis]
article5
2016Using Linked Electronic Health Records to Estimate Healthcare Costs: Key Challenges and Opportunities.(2016) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 5
article
2019An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2018Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article1
2019Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 2 2021. Contact: CitEc Team